Published in Bone on May 01, 2001
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest (2004) 4.03
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am (2013) 2.29
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest (2002) 1.99
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med (2010) 1.52
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases (2011) 1.11
Bisphosphonate treatment of bone disease. Arch Dis Child (2005) 1.00
The molecular mechanism behind bone remodelling: a review. Clin Oral Investig (2009) 0.99
[Bisphosphonate-associated osteonecrosis of the jaw]. Mund Kiefer Gesichtschir (2006) 0.92
RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro. Arthritis Res Ther (2009) 0.91
Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer (2010) 0.91
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates. Drug Des Devel Ther (2011) 0.90
Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. Clin Oral Investig (2011) 0.90
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo. Clin Exp Metastasis (2015) 0.86
Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports. Osteoporos Int (2014) 0.83
Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells. Br J Cancer (2004) 0.82
Biological targets for isatin and its analogues: Implications for therapy. Biologics (2007) 0.82
Alendronate reduces osteoclast precursors in osteoporosis. Osteoporos Int (2009) 0.82
Influence of bisphosphonate treatment on medullary macrophages and osteoclasts: an experimental study. Bone Marrow Res (2012) 0.80
In vivo effects of zoledronic acid on oral mucosal epithelial cells. Oral Dis (2010) 0.80
Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model. Dis Model Mech (2015) 0.79
Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast Cancer Res (2005) 0.78
Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma. Front Oncol (2015) 0.78
Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice. J Bone Miner Metab (2014) 0.78
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis. Clin Interv Aging (2007) 0.78
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women. Clin Interv Aging (2008) 0.77
The neurological safety of epidural pamidronate in rats. Korean J Pain (2010) 0.77
Dose-dependent differential effects of risedronate on gene expression in osteoblasts. Biochem Pharmacol (2011) 0.76
Genetics of the bone response to bisphosphonate treatments. Clin Cases Miner Bone Metab (2009) 0.76
Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci Rep (2017) 0.75
The combination therapy with zoledronic Acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis. J Osteoporos (2014) 0.75
Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo. Oncotarget (2016) 0.75
Effect of alendronate on the mandible and long bones: an experimental study in vivo. Pediatr Res (2015) 0.75
Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter. Cell J (2012) 0.75
Does pamidronate enhance the osteogenesis in mesenchymal stem cells derived from fibrous hamartoma in congenital pseudarthrosis of the tibia? Bone Rep (2016) 0.75
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res (1998) 3.65
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59
Construction of the mycoplasma evolutionary tree from 5S rRNA sequence data. Proc Natl Acad Sci U S A (1985) 3.38
Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A (1974) 3.18
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A (1999) 2.66
Bisphosphonates: from the laboratory to the clinic and back again. Bone (1999) 2.55
Anticodon and acceptor stem nucleotides in tRNA(Gln) are major recognition elements for E. coli glutaminyl-tRNA synthetase. Nature (1991) 2.39
Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol (1997) 2.14
Plasmodium: genus-conserved primers for species identification and quantitation. Exp Parasitol (1995) 1.81
Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis. Arch Biochem Biophys (2000) 1.73
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res (1997) 1.72
The binding of cytochrome b 5 to liver microsomes. J Biol Chem (1972) 1.71
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res (1991) 1.57
The cytoplasmic ribosomal RNAs of Plasmodium spp. Parasitol Today (1995) 1.56
Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem (1997) 1.51
Lipid-protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase system. J Biol Chem (1973) 1.49
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol (1999) 1.48
Apparent dependence of interactions between cytochrome b5 and cytochrome b5 reductase upon translational diffusion in dimyristoyl lecithin liposomes. Proc Natl Acad Sci U S A (1975) 1.46
A Spiroplasma tRNA gene cluster. Isr J Med Sci (1984) 1.44
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res (1998) 1.39
Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res (1995) 1.37
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des (2010) 1.37
Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res (1998) 1.36
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite. J Mol Biol (1997) 1.33
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology (2001) 1.32
Recognition of bases in Escherichia coli tRNA(Gln) by glutaminyl-tRNA synthetase: a complete identity set. EMBO J (1992) 1.31
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum (2001) 1.31
Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int (1999) 1.31
The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res (1999) 1.30
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem (2001) 1.18
Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J (2001) 1.17
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem (1999) 1.14
The nucleotide sequence of the 5S rRNA from Spiroplasma species BC3 and Mycoplasma mycoides sp. capri PG3. Nucleic Acids Res (1982) 1.10
Antibody to beta3 integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology (1996) 1.08
Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. Biochem Biophys Res Commun (1998) 1.08
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem (2000) 1.08
Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer (1991) 1.06
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma. Br J Haematol (2000) 1.06
Competition of aminoacyl-tRNA synthetases for tRNA ensures the accuracy of aminoacylation. Nucleic Acids Res (1992) 1.05
Effects of interruption of apicoplast function on malaria infection, development, and transmission. Mol Biochem Parasitol (2000) 1.05
Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J Clin Invest (1994) 1.04
Evidence for randon distribution and translational movement of cytochrome b5 in endoplasmic reticulum. J Biol Chem (1974) 1.04
Synthetase competition and tRNA context determine the in vivo identify of tRNA discriminator mutants. J Mol Biol (1992) 1.04
Transfer RNA-dependent cognate amino acid recognition by an aminoacyl-tRNA synthetase. EMBO J (1996) 1.03
Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol (1991) 1.02
Qa alloantigen expression on functional T lymphocytes from spleen and thymus. Immunogenetics (1986) 1.02
The role of prenylated small GTP-binding proteins in the regulation of osteoclast function. Calcif Tissue Int (2002) 1.00
Spatial organization of microfilaments and vitronectin receptor, alpha v beta 3, in osteoclasts. A study using confocal laser scanning microscopy. J Cell Sci (1993) 1.00
Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens. Adv Cancer Res (1980) 1.00
Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Sci (1993) 0.99
Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrance of an R-MuLV-induced leukemia. Int J Cancer (1978) 0.99
Combined study to assess the role of calcium alginate swabs and ligation of the inferior tonsillar pole in the control of intra-operative blood loss during tonsillectomy. J Laryngol Otol (1991) 0.99
Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol (1997) 0.99
Interaction of halide ions with Aspergillus niger glucose oxidase. Biochemistry (1971) 0.97
The nucleotide sequence of a tRNA gene cluster from Spiroplasma meliferum. Nucleic Acids Res (1986) 0.97
Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone (1996) 0.96
Plasmodium: the developmentally regulated ribosome. Exp Parasitol (1994) 0.95
Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Mol Pharmacol (1998) 0.95
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci (1999) 0.94
A novel method for efficient generation of transfected human osteoclasts. Calcif Tissue Int (2007) 0.94
New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos Int (2010) 0.94
Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells. J Natl Cancer Inst (1977) 0.94
Acetylation of spermidine and methylglyoxal bis(guanylhydrazone) in baby-hamster kidney cells (BHK-21/C13). Biochem J (1988) 0.93
Comparison of MHC genes among distantly related members of the genus Mus. J Immunol (1985) 0.93
The interaction of NADH-cytochrome b5 reductase and cytochrome b5 bound to egg lecithin liposomes. J Biol Chem (1975) 0.93
Adhesive properties of isolated chick osteocytes in vitro. Bone (1996) 0.92
Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl (1997) 0.91
Biochemical analysis of a 40,000 mol. wt mouse serum protein which binds beta 2-microglobulin and has serological cross-reactivity with H-2 antigens. Mol Immunol (1982) 0.91
A second dihydroorotate dehydrogenase (Type A) of the human pathogen Enterococcus faecalis: expression, purification, and steady-state kinetic mechanism. Arch Biochem Biophys (2000) 0.90
Connecting anticodon recognition with the active site of Escherichia coli glutaminyl-tRNA synthetase. J Mol Biol (1994) 0.90
Expression of a human gene for polyamine transport in Chinese-hamster ovary cells. Biochem J (1989) 0.90
Mutant enzymes and tRNAs as probes of the glutaminyl-tRNA synthetase: tRNA(Gln) interaction. Biochimie (1991) 0.90
Human osteoclastoma-derived stromal cells: correlation of the ability to form mineralized nodules in vitro with formation of bone in vivo. J Bone Miner Res (1996) 0.89
Uptake and transport of intact macromolecules in the intestinal epithelium of carp (Cyprinus carpio L.) and the possible immunological implications. Cell Tissue Res (1985) 0.88
The binding of reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase to hepatic microsomes. J Biol Chem (1974) 0.88
Osteoclasts on bone and dentin in vitro: mechanism of trail formation and comparison of resorption behavior. Calcif Tissue Int (2013) 0.87
Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor. Proc Natl Acad Sci U S A (1979) 0.87
Cytokine-activated endothelium recruits osteoclast precursors. Endocrinology (2001) 0.87
Some immunogenic acid biochemical properties of tumor-associated transplantation antigens (TATA) obtained in soluble form or solubilized from two methylcholanthrene-induced sarcomas, Meth A and CI-4. Int J Cancer (1981) 0.86
Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro. Life Sci (1998) 0.86
Escherichia coli tryptophanyl-tRNA synthetase mutants selected for tryptophan auxotrophy implicate the dimer interface in optimizing amino acid binding. Biochemistry (1996) 0.86
Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J Bone Miner Res (1993) 0.86
Site-directed mutagenesis to fine-tune enzyme specificity. Protein Eng (1988) 0.85
Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones. A model for in vitro study of human osteoclast formation and function. Cell Tissue Res (1987) 0.85
Separation of the tumor-associated transplantation antigen (TATA) from the alien H-2k antigens expressed on a methylcholanthrene-induced tumor. Int J Cancer (1980) 0.85
Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins. Bone (1995) 0.84
Statins: lower lipids and better bones? Nat Med (2000) 0.84
Dihydroorotate dehydrogenase B of Enterococcus faecalis. Characterization and insights into chemical mechanism. Biochemistry (1999) 0.84